About Bethany Howell

Articles by Bethany Howell

Study Explores Benefits of Outpatient Induction Therapy for AML
Oct 23, 2026
What Are the Different Types of Leukemia?
Oct 20, 2026
Why Does Tagraxofusp (Elzonris) Stop Working for Some People With BPDCN?
Oct 08, 2026
Research for Rare Cancer: Why Patient Data Matters
Sep 29, 2026
Is Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Hereditary?
Sep 15, 2026
What Are Orphan Drugs? A Guide for Rare Cancer Patients
Sep 10, 2026
Jose’s Story: Finding Strength Through Art and Positivity
Sep 04, 2026
Raising Awareness About Blood Cancer in September
Aug 31, 2026
Why Words Matter When Talking About Cancer
Aug 30, 2026
Multiple Myeloma in Young Adults: Brice Davis’ Story
Aug 23, 2026
Connect to Cures in Des Moines, Iowa
Aug 23, 2026
Heat Intolerance After a Stem Cell Transplant
Aug 23, 2026
$Inotuzumab Ozogamicin (Besponsa) Therapy Helps People with Relapsed or Refractory B-Cell ALL Reach MRD Negativity image$

Inotuzumab Ozogamicin (Besponsa) Therapy Helps People with Relapsed or Refractory B-Cell ALL Reach MRD Negativity
Aug 17, 2026
¿Puede la terapia con células CAR-T causar la caída del cabello?
Aug 17, 2026
Childhood Leukemia Symptoms: Early Signs Parents Should Know
Aug 17, 2026
La FDA aprueba isatuximab-irfc para mieloma múltiple
Aug 13, 2026
Adult AML Survivors Have a Higher Risk of Second Cancers
Aug 09, 2026
Study Shows Two Years of Maintenance Therapy May Be Enough for Some People With Multiple Myeloma
Aug 07, 2026
Adult Survivors of Childhood Cancer Experience High Rates of Disability and Financial Hardship
Jul 27, 2026
Genetic Changes Found in BPDCN in Children
Jul 27, 2026
How to Help Children With Cancer Eat Well: Nutrition Tips for Parents and Caregivers
Jul 14, 2026
New Research on Fertility After Cancer
Jul 12, 2026
FDA Approves Sarclisa Escena for Multiple Myeloma
Jul 10, 2026
Does CAR T-Cell Therapy Cause Hair Loss?
Jul 01, 2026